These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2582428)

  • 1. Inhibition of platelet aggregation by a monoclonal antibody against human fibronectin.
    Dixit VM; Haverstick DM; O'Rourke K; Hennessy SW; Broekelmann TJ; McDonald JA; Grant GA; Santoro SA; Frazier WA
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3844-8. PubMed ID: 2582428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on fibronectin and its domains. I. Novel recombinant cell-binding domain of fibronectin--a modulator of human platelet functions.
    Vogel T; Werber MM; Guy R; Levanon A; Nimrod A; Legrand C; Gorecki M; Eldor A; Panet A
    Arch Biochem Biophys; 1993 Jan; 300(1):501-9. PubMed ID: 8424687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of fibronectin in platelet aggregation.
    Thurlow PJ; Kenneally DA; Connellan JM
    Br J Haematol; 1990 Aug; 75(4):549-56. PubMed ID: 2207006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
    Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
    Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-(Arg-Gly-Asp-Ser) antibody and its interaction with fibronectin, fibrinogen and platelets.
    Cierniewski CS; Swiatkowska M; Poniatowski J; Niewiarowska J
    Eur J Biochem; 1988 Oct; 177(1):109-15. PubMed ID: 2460346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of fibronectin-coated beads with CHO cells.
    Schwarz MA; Juliano RL
    Exp Cell Res; 1984 Jun; 152(2):302-12. PubMed ID: 6373325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesive responses of fibroblast and neuroblastoma cells to substrata coated with polyvalent or monoclonal antibody to fibronectin.
    Harrison DD; Culp LA
    Exp Cell Res; 1983 Jun; 146(1):29-42. PubMed ID: 6861909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptokinase and human fibronectin share a common epitope: implications for regulation of fibrinolysis and rheumatoid arthritis.
    Gonzalez-Gronow M; Enghild JJ; Pizzo SV
    Biochim Biophys Acta; 1993 Jan; 1180(3):283-8. PubMed ID: 7678505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet aggregation by fibronectin.
    Santoro SA
    Biochem Biophys Res Commun; 1983 Oct; 116(1):135-40. PubMed ID: 6416252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin increases expression of fibronectin antigen on the platelet surface.
    Ginsberg MH; Painter RG; Forsyth J; Birdwell C; Plow EF
    Proc Natl Acad Sci U S A; 1980 Feb; 77(2):1049-53. PubMed ID: 6987662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody against human thrombospondin inhibits platelet aggregation.
    Dixit VM; Haverstick DM; O'Rourke KM; Hennessy SW; Grant GA; Santoro SA; Frazier WA
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3472-6. PubMed ID: 2582413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic peptide, FN-C/H-V, from the C-terminal heparin-binding domain of fibronectin promotes adhesion of PMA stimulated U937 cells.
    Kato K; Mohri H; Tamura T; Okubo T
    Biochem Biophys Res Commun; 1997 Oct; 239(1):205-11. PubMed ID: 9345296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody against the N-terminal end of human plasma fibronectin.
    Vartio T; Salonen EM; De Petro G; Barlati S; Miggiano V; Stähli C; Virgallita G; Takács B; Vaheri A
    Biochem J; 1983 Oct; 215(1):147-51. PubMed ID: 6194791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adhesion to fibronectin primes eosinophils via alpha 4 beta 1 (VLA-4).
    Anwar AR; Walsh GM; Cromwell O; Kay AB; Wardlaw AJ
    Immunology; 1994 Jun; 82(2):222-8. PubMed ID: 7927493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat plasma fibronectin contains two distinct chemotactic domains for fibroblastic cells.
    Fukai F; Suzuki H; Suzuki K; Tsugita A; Katayama T
    J Biol Chem; 1991 May; 266(14):8807-13. PubMed ID: 2026595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma fibronectin-C1q complex formation and its effect on C1q inhibition of collagen-induced platelet aggregation.
    Wautier JL; Wautier MP; Kadeva H; Mosesson MW
    Thromb Res; 1983 Nov; 32(3):283-90. PubMed ID: 6606861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies that distinguish between human cellular and plasma fibronectin.
    Keen J; Chang SE; Taylor-Papadimitriou J
    Mol Biol Med; 1984 Feb; 2(1):15-27. PubMed ID: 6083431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of two monoclonal antibodies that recognize remote epitopes on the cell-binding domain of human fibronectin.
    Katayama M; Hino F; Odate Y; Goto S; Kimizuka F; Kato I; Titani K; Sekiguchi K
    Exp Cell Res; 1989 Nov; 185(1):229-36. PubMed ID: 2478378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous fibronectin modifies the aggregation of collagen-stimulated human platelets.
    Eynard AR; Pasqualini ME; Rovasio RA
    Experientia; 1990 Jul; 46(7):680-2. PubMed ID: 2373194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chimeric monoclonal antibody MHCSZ-123 against human von Willebrand factor A3 domain inhibits high-shear arterial thrombosis in a Rhesus monkey model.
    Ji S; Jiang M; Yan B; Shen F; He Y; Wan A; Xia L; Ruan C; Zhao Y
    J Hematol Oncol; 2017 May; 10(1):111. PubMed ID: 28526067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.